Korpi Capital invests in biotechnology solutions provider BIONTO Oy
BIONTO Oy was founded by Dr. Terhi Puranen, Dr. Marika Alapuranen and Katja Palmunen. The company specializes in utilizing biological components as final products or process fillers.
These components may include enzymes, proteins, sugars, or fats.
BIONTO Oy’s core expertise lies in Trichoderma reesei fungus-based cell production technology, its industrial development, and application. The company's founders have over 20 years of experience in developing commercial industrial enzyme products, industrial production processes, and building intellectual property rights (IPR). BIONTO offers product development and production services, covering the entire development process from concept to product, or specific parts of it according to the customer’s needs.
Additional information:
Terhi Puranen
CEO